Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New custom contact lenses tested for astigmatism

NCT ID NCT06785194

Knowledge-focused Sponsor: Bausch & Lomb Incorporated Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well REVIVE samfilcon B custom toric contact lenses work for people with astigmatism. About 30 adults will wear the lenses, and eye doctors will rate their satisfaction after 14 days. The goal is to see if these lenses provide clear vision and are easy to use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
REVIVE samfilcon B custom toric contact lenses
What this could lead to
If successful, this study could confirm that these custom toric lenses provide good vision and satisfaction for people with astigmatism.
What could go wrong
This is a small, observational study with only 30 participants, so results may not apply to everyone. It does not test new treatments or compare with other lenses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient population at study site locations

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Be 18 years or older on the date the ICF is signed 2. Have the capacity to read, understand, and provide written voluntary informed consent 3. Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings 4. Have no active ocular disease or allergic conjunctivitis 5. Not be using any topical ocular medications 6. Be willing and able to follow instructions 7. Have signed a statement of informed consent 8. Be an experienced soft contact lens wearer (have previously used soft contact lenses) 9. Meet the indications per the Instructions for Use (IFU) and have a suitable prescription for treatment with the device Exclusion Criteria: 1. Is participating in another research study 2. Is considered by the Investigator to not be a suitable candidate for participation 3. Is not eligible for treatment with the study lens per the IFU (contraindicated) 4. Has had previous ocular surgery 5. Is taking/using ocular, systemic, or topical medications that, in the Investigator's opinion, could potentially affect ocular physiology or lens/solution performance

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

astigmatism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Astigmatism

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Site 101

    Orange Park, Florida, 32073, United States

  • Site 102

    Orange Park, Florida, 32073, United States

  • Site 103

    Canton, Georgia, 30114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.